Global Assets Advisory’s Elevance Health ELV Stock Holding History

Global Assets Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-371	Closed	-$109K	–	383
2026 Q1	$109K	Buy	+371	New	+$122K	0.03%	292
2025 Q2	–	Sell	-1,266	Closed	-$548K	–	244
2025 Q1	$548K	Buy	+1,266	New	+$508K	0.1%	155
2024 Q4	–	Sell	-523	Closed	-$267K	–	156
2024 Q3	$267K	Buy	523 +133	+34%	+$71.1K	0.15%	137
2024 Q2	$211K	Sell	390 -19	-5%	-$10K	0.34%	57
2024 Q1	$211K	Buy	+409	New	+$203K	0.13%	134
2023 Q4	–	Sell	-546	Closed	-$238K	–	73
2023 Q3	$238K	Buy	+546	New	+$248K	0.21%	109
2023 Q2	–	Sell	-441	Closed	-$213K	–	119
2023 Q1	$213K	Sell	441 -480	-52%	-$228K	0.22%	107
2022 Q4	$472K	Sell	921 -379	-29%	-$192K	0.5%	59
2022 Q3	$711K	Buy	1,300 +481	+59%	+$230K	0.72%	36
2022 Q2	$387K	Buy	+819	New	+$405K	0.83%	33

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Global Assets Advisory's ELV Position: Q2 2026 in Review

Global Assets Advisory sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 371 shares — an estimated $109K sold.

Global Assets Advisory first reported a position in ELV in Q2 2022 and held it in 10 quarters. The position peaked at $711K in Q3 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Global Assets Advisory reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Global Assets Advisory sold 371 Elevance Health shares in Q2 2026, an estimated $109K.
Global Assets Advisory first reported a position in Elevance Health in Q2 2022 and held it in 10 quarters.
Global Assets Advisory's Elevance Health position peaked at $711K in Q3 2022.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.